CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		20,736,612
Beginning balance at Dec. 31, 2023	$ 12,656	$ 2	$ 737,829	$ (725,175)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		3,821,362
Issuance of common stock	12,193		12,188	5
Vesting of restricted stock units (in shares)		317,613
5-Year Private Warrants transferred to 5-Year Public Warrants	5		5
Stock-based compensation costs	2,627		2,627
Net loss	$ (60,896)			(60,896)
Ending balance (in shares) at Dec. 31, 2024	24,875,587	24,875,587
Ending balance at Dec. 31, 2024	$ (33,415)	$ 2	752,649	(786,066)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		55,192,481
Issuance of common stock	274,579	$ 6	274,573
Voluntary surrender of shares by shareholder (in shares)		(301)
Exercise of warrants (in shares)		2,592,218
Exercise of warrants	11,299		11,299
Vesting of restricted stock units (in shares)		365,399
Stock-based compensation costs	1,896		1,896
Net loss	$ (40,664)			(40,664)
Ending balance (in shares) at Dec. 31, 2025	83,025,384	83,025,384
Ending balance at Dec. 31, 2025	$ 213,695	$ 8	$ 1,040,417	$ (826,730)